Abstract:How rapid HIV infection progresses to AIDS and to death is affected by different factors. This study explores survival times and associated survival factors from treatment initiation to death or censoring in antiretroviral therapy-experienced HIV-seropositive adults in Malawi from 2004-2015. A multicentre non-concurrent, retrospective cohort study was undertaken from eight ART Centres where patients’ medical records (PMRs) of HIV-positive adult patients aged 15+ years were reviewed. A life table, the Kaplan-Meier log-rank, and Cox Proportion Hazard regression were used to calculate survival time-to-death and its correlates, respectively. Hazard ratio with 95%CI and p<0.05 were used to declare statistical significance. Data for (n=9,953) patients were abstracted from PMRs. Patients median age was 40 (IQR: 33-48 years). 60.8% were females, 45.2% were aged 20-39 years, and 78.8% were married. At treatment initiation, 48.1% had advanced HIV disease clinical stage III, 24.5% had WHO stage IV, whereas 27.5% were asymptomatic – of which, 24.9% and 2.6% initiated ART due to low CD4+ count and PMTCT’s Option-B+ eligibility criteria, respectively. Survival function findings revealed that each patient had a single entry into the study. Exit time ranged from 1 to 9,224 days with the mean value of 2,421.9 days, occurring at the rate of 0.00004883 event-failure per-person-day. Time-to-death was observed at the rate of 1.78/100 person-years-at-risk (PYAR). 213 deaths (18.1%) occurred early in year-one post-ART-initiation. Deaths occurred more among persons of 20-39 years (N=470, 39.97%), and of 40-54 years (N=483, 41.07%), and was mostly due to mycobacterial pathogenic conditions (N=106, 37.3%) in particular TB infection (N=103); most of which were PTB cases (N=69, 66.9%). Mortality was high in Southern region (63.1%, N=743) but was least in Northern region (N=313) [ 0.0001]. In a multivariate Cox regression predictive model, males gender (aHR=1.42), patients age-groups of 20-39 years (aHR=1.63), 40-54 years (aHR=1.71), and 55+ years (aHR=2.66), Mzuzu Central hospital ART centre (aHR=2.66), Thyolo District hospital ART centre (aHR=3.02), semi-rural areas (aHR=1.30), urban areas (aHR=0.80), being single (aHR=0.86), chronic cough and/or breathlessness (aHR=1.19), chronic diarrhoea or weight loss (aHR=1.43), chronic fever and/or severe headache (aHR=1.30), skin or oral lesion (aHR=1.33), WHO clinical stage III (aHR=17.90), WHO clinical stage IV (aHR=20.09), low baseline CD4 count <250 cells/µL, (aHR=1.17), high baseline VL>1,000 copies/mL (aHR=2.46), Nevirapine-based therapies (aHR=1.14), and HIV duration of 3-5 years (aHR=1.17), 6-10 years (aHR=1.19) and >10 years (aHR=1.16) were all statistically significantly associated with time-to-death. This study has demonstrated survival factors associated with time-to-death among HIV-positive adults in Malawi. In order to effectively reduce AIDS mortality and win the war against AIDS-related death, the need to critically address and carefully prioritise the identified factors in HIV/AIDS management is great and cannot be overemphasised.

Changes in early HIV/AIDS mortality rates in people initiating antiretroviral treatment between 2013 and 2023: A 10-year multicenter survival study in Senegal

Survival and Predictors of Mortality among Adults Initiating Highly Active Antiretroviral Therapy in Ethiopia: A Retrospective Cohort Study (2007-2019)

High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

Survival and predictors of mortality among HIV-infected adults after initiation of antiretroviral therapy in Eastern Ethiopia Governmental hospitals, from January 2015 to December 2021 (multi-center retrospective follow-up study)

Survival trends among people living with human immunodeficiency virus on antiretroviral treatment in two rural districts in Ghana

Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies

Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study

Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication

Changing Mortality and Patterns of Death Causes in HIV Infected Patients - China, 2013-2022

Mortality and comorbidities in a Nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults’ cohort, France, 2006–18

Highly active antiretroviral therapy is necessary but not sufficient. A systematic review and meta-analysis of mortality incidence rates and predictors among HIV-infected adults receiving treatment in Ethiopia, a surrogate study for resource-poor settings

Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study

Mortality and Its Predictors among Adult Human Immune-Deficiency Virus-Infected Patients Attending Their Antiretroviral Treatment at Health Centers, Addis Ababa, Ethiopia: Multicenter Retrospective Cohort Study

The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Côte d'Ivoire, Mali, and Senegal

Analysis of Time-to-Death Survival Function in a Nationally Representative Random Sample of HIV-seropositive Treatment-experienced Adult Patients from Malawi – A Historical Cohort Sample of 2004-2015 HIV Data

Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998–2020

Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific

Survival analysis of PLWHA undergoing combined antiretroviral therapy: exploring long-term prognosis and influencing factors

Mortality variability and differentials by age and causes of death in rural South Africa, 1994–2018